Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV003487157 | SCV004240062 | uncertain significance | Cardiomyopathy | 2023-06-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004992616 | SCV005521515 | uncertain significance | Cardiovascular phenotype | 2024-08-15 | criteria provided, single submitter | clinical testing | The c.37982_37984delAAG variant (also known as p.E12661del) is located in coding exon 138 of the TTN gene. This variant results from an in-frame AAG deletion at nucleotide positions 37982 to 37984. This results in the in-frame deletion of a glutamic acid at codon 12661. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear. |